Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0005764 lysosome	IBA GO_REF:0000033	ACCEPT	Summary: Phylogenetically inferred lysosomal localization is strongly supported by experimental evidence. DRAM2 has been directly shown to localize to lysosomes by immunofluorescence in multiple studies [PMID:19556885, PMID:19895784]. Recent patient-derived iPSC studies confirm DRAM2 enrichment on lysosomal membranes with co-localization to LAMP2+ compartments [Tsikandelova 2024]. Reason: IBA annotation is consistent with direct experimental evidence from multiple independent studies demonstrating lysosomal localization by immunofluorescence and co-localization with lysosomal markers LAMP1/2. Supporting Evidence: PMID:19556885 DRAM2 is also a lysosomal protein PMID:19895784 DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM file:human/DRAM2/DRAM2-deep-research-falcon.md DRAM2 shows punctate vesicular localization enriched on lysosomal membranes in human retinal organoids; it nests within/adjacent to LAMP2+ compartments
GO:0010506 regulation of autophagy	IBA GO_REF:0000033	ACCEPT	Summary: Phylogenetically inferred role in autophagy regulation is consistent with the protein family's function. DRAM2 belongs to the DRAM/TMEM150 family characterized by autophagy modulation. Experimental evidence demonstrates DRAM2 involvement in autophagic flux: patient-derived cells show impaired LC3 lipidation responses [Tsikandelova 2024]. DRAM2 loss causes defects in autophagy initiation/maturation affecting the BECN1/RUBCN axis. Reason: Core function of DRAM2 supported by family membership and experimental evidence showing impaired autophagic flux (LC3 lipidation defects) in DRAM2-deficient human retinal cells. Supporting Evidence: PMID:19895784 Damage-regulated autophagy regulator (DRAM) has been identified as an effector molecule that is critical for p53-mediated apoptosis, and we investigated whether there might be other DRAM-like molecules linking autophagy and apoptosis file:human/DRAM2/DRAM2-deep-research-falcon.md DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II changes with bafilomycin/rapamycin)
GO:0045494 photoreceptor cell maintenance	IBA GO_REF:0000033	ACCEPT	Summary: Phylogenetically inferred role in photoreceptor maintenance is strongly supported by human genetic and functional data. Biallelic mutations in DRAM2 cause cone-rod dystrophy 21 (CORD21) characterized by photoreceptor degeneration [PMID:25983245]. DRAM2 localizes to photoreceptor inner segments and is involved in photoreceptor renewal and recycling. Patient-derived iPSC retinal organoids show photoreceptor dysfunction [Tsikandelova 2024]. Reason: Core function in retinal biology. Human genetic evidence demonstrates that DRAM2 loss causes photoreceptor degeneration (CORD21). Mouse models confirm age-related photoreceptor degeneration with Dram2 loss. Supporting Evidence: PMID:25983245 DRAM2 encodes a transmembrane lysosomal protein thought to play a role in the initiation of autophagy. Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments and to the apical surface of retinal pigment epithelial cells where it might be involved in the process of photoreceptor renewal and recycling to preserve visual function. file:human/DRAM2/DRAM2-deep-research-falcon.md Biallelic DRAM2 (TMEM77) causes autosomal-recessive cone-rod dystrophy (CORD21)
GO:0001917 photoreceptor inner segment	IEA GO_REF:0000120	ACCEPT	Summary: Computational annotation of photoreceptor inner segment localization is supported by immunohistochemical evidence in human and mouse retina. PMID:25983245 directly demonstrated DRAM2 localization to photoreceptor inner segments by immunohistochemistry. Reason: IEA annotation is correct and supported by direct experimental evidence from immunohistochemistry showing DRAM2 in photoreceptor inner segments. Supporting Evidence: PMID:25983245 Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments
GO:0005765 lysosomal membrane	IEA GO_REF:0000044	ACCEPT	Summary: UniProt subcellular location-based annotation of lysosomal membrane localization is accurate. DRAM2 is a six-pass transmembrane protein confirmed to reside in lysosomal membranes by immunofluorescence [PMID:19556885, PMID:19895784] and co-localization with lysosomal markers LAMP1/2 [Tsikandelova 2024]. Reason: Accurate IEA annotation consistent with the protein's documented localization as a multi-pass lysosomal membrane protein. Supporting Evidence: PMID:19556885 DRAM2 is also a lysosomal protein PMID:19895784 DRAM2 is mainly localized in the lysosome
GO:0006914 autophagy	IEA GO_REF:0000043	ACCEPT	Summary: UniProt keyword-based annotation of autophagy involvement is appropriate. DRAM2 regulates autophagic flux as demonstrated by impaired LC3 lipidation in DRAM2-deficient cells. The protein name itself (DNA damage-regulated autophagy modulator protein 2) reflects this core function. However, this is a parent term of 'regulation of autophagy' (GO:0010506) which is also annotated with experimental evidence. Reason: Accurate IEA annotation. DRAM2 is legitimately involved in autophagy as part of its core function regulating autophagic flux. This broader term complements the more specific 'regulation of autophagy' annotation. Supporting Evidence: PMID:19895784 Damage-regulated autophagy regulator (DRAM) has been identified as an effector molecule that is critical for p53-mediated apoptosis, and we investigated whether there might be other DRAM-like molecules linking autophagy and apoptosis
GO:0006915 apoptotic process	IEA GO_REF:0000043	KEEP AS NON CORE	Summary: UniProt keyword-based annotation derives from experimental work showing DRAM2 co-expression with DRAM1 induces apoptosis [PMID:19895784]. However, DRAM2 alone does not induce cell death; the apoptotic effect requires DRAM1 co-expression. This appears to be a secondary effect rather than a direct function. Reason: DRAM2 alone does not induce apoptosis. The apoptotic effect requires DRAM1 co-expression, suggesting this is an indirect effect mediated through autophagy-apoptosis crosstalk rather than a direct DRAM2 function. Keeping as non-core to reflect this indirect relationship. Supporting Evidence: PMID:19895784 While expression of DRAM or DRAM2 individually did not induce cell death, co-expression of DRAM2 with DRAM significantly induced cell death
GO:0016324 apical plasma membrane	IEA GO_REF:0000120	ACCEPT	Summary: Computational annotation of apical plasma membrane localization is supported by experimental evidence in retinal pigment epithelial cells. PMID:25983245 showed DRAM2 localizes to the apical surface of RPE cells. Reason: Accurate IEA annotation supported by immunohistochemical evidence showing DRAM2 at the apical surface of RPE cells. This localization is relevant to DRAM2's role in photoreceptor outer segment phagocytosis and renewal. Supporting Evidence: PMID:25983245 Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments and to the apical surface of retinal pigment epithelial cells
GO:0045494 photoreceptor cell maintenance	IEA GO_REF:0000107	ACCEPT	Summary: Ensembl Compara orthology-based transfer of photoreceptor cell maintenance annotation is correct. DRAM2 mutations cause CORD21, demonstrating essential role in photoreceptor survival. This duplicates the IBA annotation with the same GO term. Reason: Accurate IEA annotation consistent with human genetic evidence (CORD21) and experimental studies. Duplicate of IBA annotation for same term is acceptable - different evidence tracks support the same annotation. Supporting Evidence: PMID:25983245 DRAM2 encodes a transmembrane lysosomal protein thought to play a role in the initiation of autophagy... involved in the process of photoreceptor renewal and recycling to preserve visual function
GO:0005794 Golgi apparatus	IDA GO_REF:0000052	KEEP AS NON CORE	Summary: HPA immunofluorescence-based annotation suggests Golgi apparatus localization. Recent detailed localization studies in human retinal organoids show DRAM2 proximity to cis-Golgi (GM130) consistent with trafficking through the Golgi during biosynthesis and its role in adaptor-mediated vesicular trafficking [Tsikandelova 2024]. However, the primary functional localization is lysosomal. Reason: Golgi localization likely reflects trafficking during biosynthesis or transient association during vesicular transport. The primary functional localization is the lysosomal membrane. Marking as non-core since this represents a secondary localization. Supporting Evidence: PMID:19895784 DRAM2 is mainly localized in the lysosome file:human/DRAM2/DRAM2-deep-research-falcon.md DRAM2 shows proximity to cis-Golgi (GM130) and mitochondria (TOMM20), consistent with roles at organelle contact/trafficking interfaces
GO:0016324 apical plasma membrane	ISS GO_REF:0000024	ACCEPT	Summary: Sequence similarity-based annotation of apical plasma membrane localization is supported by direct experimental evidence in human tissue. PMID:25983245 demonstrated DRAM2 at the apical surface of RPE cells by immunohistochemistry. This duplicates the IEA annotation for the same term. Reason: Accurate ISS annotation supported by direct experimental evidence in human retinal tissue. Duplicate entries with different evidence codes are acceptable. Supporting Evidence: PMID:25983245 Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments and to the apical surface of retinal pigment epithelial cells
GO:0045494 photoreceptor cell maintenance	IMP PMID:25983245 Biallelic mutations in the autophagy regulator DRAM2 cause r...	ACCEPT	Summary: Direct experimental evidence from human genetic studies. Biallelic mutations in DRAM2 cause CORD21, characterized by progressive photoreceptor degeneration with early macular involvement. This provides inferred from mutant phenotype evidence that DRAM2 is required for photoreceptor cell maintenance. Reason: Core function of DRAM2 in retina. Strong IMP evidence from multiple independent families showing that DRAM2 loss-of-function mutations cause photoreceptor degeneration. Supporting Evidence: PMID:25983245 Biallelic mutations in the autophagy regulator DRAM2 cause retinal dystrophy with early macular involvement... five families affected by an adult-onset retinal dystrophy with early macular involvement and associated central visual loss in the third or fourth decade of life. Affected individuals were found to harbor disease-causing variants in DRAM2
GO:0001917 photoreceptor inner segment	ISS GO_REF:0000024	ACCEPT	Summary: Sequence similarity-based annotation of photoreceptor inner segment localization is directly supported by experimental evidence in human tissue. PMID:25983245 demonstrated DRAM2 in photoreceptor inner segments by immunohistochemistry. Reason: Accurate ISS annotation supported by direct experimental evidence in human retinal tissue. Supporting Evidence: PMID:25983245 Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments
GO:0007601 visual perception	IMP PMID:25983245 Biallelic mutations in the autophagy regulator DRAM2 cause r...	KEEP AS NON CORE	Summary: Human genetic evidence demonstrates DRAM2 is required for visual perception. Patients with biallelic DRAM2 mutations develop visual loss in the third or fourth decade of life with progressive deterioration. This is a downstream consequence of DRAM2's role in photoreceptor maintenance rather than a direct molecular function. Reason: Visual perception loss is a phenotypic consequence of DRAM2 deficiency rather than a direct cellular function. The proximate role is in photoreceptor/RPE cell maintenance via autophagy and lysosomal function; visual perception is the organismal outcome. Marking as non-core but retaining as it accurately reflects the human disease phenotype. Supporting Evidence: PMID:25983245 five families affected by an adult-onset retinal dystrophy with early macular involvement and associated central visual loss in the third or fourth decade of life
GO:0010506 regulation of autophagy	IDA PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes...	ACCEPT	Summary: Direct experimental evidence demonstrates DRAM2 involvement in autophagy regulation. While the initial study (PMID:19895784) found DRAM2 overexpression alone did not modulate autophagy (unlike DRAM1), subsequent studies with patient-derived cells show DRAM2 loss impairs autophagic flux (LC3 lipidation defects) [Tsikandelova 2024]. DRAM2 functions in autophagy regulation through a different mechanism than DRAM1. Reason: Core function supported by protein family membership and loss-of-function studies. While overexpression studies were initially negative, patient cell studies clearly demonstrate DRAM2 is required for normal autophagic flux. The IDA annotation reflects DRAM2's involvement in autophagy regulation pathways. Supporting Evidence: PMID:19895784 Damage-regulated autophagy regulator (DRAM) has been identified as an effector molecule that is critical for p53-mediated apoptosis, and we investigated whether there might be other DRAM-like molecules linking autophagy and apoptosis file:human/DRAM2/DRAM2-deep-research-falcon.md DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II changes with bafilomycin/rapamycin)
GO:0005737 cytoplasm	IDA PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes...	MARK AS OVER ANNOTATED	Summary: Cytoplasmic localization is a very broad term. While technically accurate (the lysosome is in the cytoplasm), this annotation provides limited information given the more specific lysosomal membrane localization that is well-established. DRAM2 is primarily a membrane protein of lysosomes. Reason: Cytoplasm is too general and uninformative given the specific lysosomal membrane localization. DRAM2 is an integral membrane protein of lysosomes; annotating to 'cytoplasm' adds no meaningful information and may obscure the specific localization. Supporting Evidence: PMID:19895784 DRAM2 is mainly localized in the lysosome
GO:0005764 lysosome	IDA PMID:19556885 Analysis of DRAM-related proteins reveals evolutionarily con...	ACCEPT	Summary: Direct experimental evidence from O'Prey et al. demonstrating DRAM2 lysosomal localization. The study showed DRAM2 is a lysosomal protein through immunofluorescence analysis. Reason: Core localization supported by direct experimental evidence. DRAM2 was shown to be a lysosomal protein in this study characterizing DRAM family members. Supporting Evidence: PMID:19556885 DRAM2 is also a lysosomal protein
GO:0005764 lysosome	IDA PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes...	ACCEPT	Summary: Direct experimental evidence from Park et al. demonstrating DRAM2 lysosomal localization. The study showed DRAM2 is mainly localized in the lysosome and co-localizes with DRAM1. Reason: Core localization supported by direct experimental evidence through immunofluorescence showing lysosomal localization and co-localization with DRAM1. Supporting Evidence: PMID:19895784 DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM

References

GO_REF:0000024

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt

GO_REF:0000052

Gene Ontology annotation based on curation of immunofluorescence data

GO_REF:0000107

Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:19556885

Analysis of DRAM-related proteins reveals evolutionarily conserved and divergent roles in the control of autophagy.

DRAM2 is a lysosomal protein

"DRAM2 is also a lysosomal protein"
DRAM2 shows 45% identity and 67% conservation compared to DRAM1

"The closest of these, which we have termed DRAM2, displays 45% identity and 67% conservation when compared to DRAM"
DRAM2 is not induced by p53 or p73 (unlike DRAM1)

"DRAM2 is different from DRAM as it not induced by p53 or p73"
DRAM2 overexpression alone does not modulate autophagy (unlike DRAM1)

"DRAM2 is also a lysosomal protein, but again unlike DRAM its overexpression does not modulate autophagy"

PMID:19895784

Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death.

DRAM2 is mainly localized in the lysosome

"DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM"
DRAM2 co-localizes with DRAM1

"DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM"
DRAM2 expression is down-regulated in ovarian tumors

"the expression of DRAM2 is down-regulated in ovarian tumors"
DRAM2 alone does not induce cell death

"While expression of DRAM or DRAM2 individually did not induce cell death"
Co-expression of DRAM2 with DRAM1 induces cell death

"co-expression of DRAM2 with DRAM significantly induced cell death"
DRAM2 knockdown attenuates cell death

"silencing of endogenous DRAM2 attenuated cell death"

PMID:25983245

Biallelic mutations in the autophagy regulator DRAM2 cause retinal dystrophy with early macular involvement.

Biallelic DRAM2 mutations cause cone-rod dystrophy 21 (CORD21)

"Affected individuals were found to harbor disease-causing variants in DRAM2"
Disease characterized by adult-onset retinal dystrophy with early macular involvement

"five families affected by an adult-onset retinal dystrophy with early macular involvement"
Visual loss typically occurs in third or fourth decade of life

"associated central visual loss in the third or fourth decade of life"
DRAM2 localizes to photoreceptor inner segments

"Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments"
DRAM2 localizes to apical surface of retinal pigment epithelial cells

"Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments and to the apical surface of retinal pigment epithelial cells"
DRAM2 may be involved in photoreceptor renewal and recycling

"where it might be involved in the process of photoreceptor renewal and recycling to preserve visual function"

file:human/DRAM2/DRAM2-deep-research-falcon.md

Deep research review of DRAM2 function

DRAM2 deficiency causes impaired autophagic flux

"DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II changes with bafilomycin/rapamycin)"
DRAM2 loss causes lysosomal enzyme deficiencies

"reduced activities of key lysosomal enzymes (cathepsin D, GBA, a-mannosidase; severe PPT1/NPC2 deficiency with extracellular mis-secretion)"
DRAM2 co-localizes with AP-1 and AP-3 adaptor complexes

"Proteomics indicated downregulation of clathrin adaptors AP-1/AP-3, with DRAM2 co-staining with these adaptors"

Suggested Experiments

Experiment: Proximity ligation assays (PLA) or BioID/TurboID proximity labeling to map DRAM2 interactors at the lysosomal membrane

Hypothesis: DRAM2 directly interacts with AP-1/AP-3 adaptor complexes and/or autophagy machinery components at the lysosomal membrane

Experiment: CRISPR-based functional screens in human retinal organoids to identify genetic modifiers of DRAM2-related phenotypes

Hypothesis: Genes involved in lysosomal biogenesis, autophagy, or lipid metabolism will modify DRAM2-deficient phenotypes

Experiment: Live imaging studies with fluorescent DRAM2 to track its dynamics during autophagy induction and lysosomal biogenesis

Hypothesis: DRAM2 shows dynamic trafficking between Golgi and lysosomes during autophagy induction

📚 Additional Documentation

Deep Research Falcon

(DRAM2-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-19T08:57:50.991853'
end_time: '2026-01-19T09:04:33.096304'
duration_seconds: 402.1
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: DRAM2
gene_symbol: DRAM2
uniprot_accession: Q6UX65
protein_description: 'RecName: Full=DNA damage-regulated autophagy modulator protein
2; AltName: Full=Transmembrane protein 77;'
gene_info: Name=DRAM2; Synonyms=TMEM77; ORFNames=PSEC0031, UNQ154/PRO180;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the DRAM/TMEM150 family. .
protein_domains: DRAM/TMEM150_Autophagy_Mod. (IPR050911); Frag1/DRAM/Sfk1. (IPR019402);
Frag1 (PF10277)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 17

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

UniProt Accession: Q6UX65
Protein Description: RecName: Full=DNA damage-regulated autophagy modulator protein 2; AltName: Full=Transmembrane protein 77;
Gene Information: Name=DRAM2; Synonyms=TMEM77; ORFNames=PSEC0031, UNQ154/PRO180;
Organism (full): Homo sapiens (Human).
Protein Family: Belongs to the DRAM/TMEM150 family. .
Key Domains: DRAM/TMEM150_Autophagy_Mod. (IPR050911); Frag1/DRAM/Sfk1. (IPR019402); Frag1 (PF10277)

MANDATORY VERIFICATION STEPS:

Check if the gene symbol "DRAM2" matches the protein description above
Verify the organism is correct: Homo sapiens (Human).
Check if protein family/domains align with what you find in literature
If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'DRAM2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene DRAM2 (gene ID: DRAM2, UniProt: Q6UX65) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

UniProt Accession: Q6UX65
Protein Description: RecName: Full=DNA damage-regulated autophagy modulator protein 2; AltName: Full=Transmembrane protein 77;
Gene Information: Name=DRAM2; Synonyms=TMEM77; ORFNames=PSEC0031, UNQ154/PRO180;
Organism (full): Homo sapiens (Human).
Protein Family: Belongs to the DRAM/TMEM150 family. .
Key Domains: DRAM/TMEM150_Autophagy_Mod. (IPR050911); Frag1/DRAM/Sfk1. (IPR019402); Frag1 (PF10277)

MANDATORY VERIFICATION STEPS:

Check if the gene symbol "DRAM2" matches the protein description above
Verify the organism is correct: Homo sapiens (Human).
Check if protein family/domains align with what you find in literature
If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Please provide a comprehensive research report on the gene DRAM2 (gene ID: DRAM2, UniProt: Q6UX65) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Research plan status and verification
- Identity verification: The target is human DRAM2 (aka TMEM77), UniProt Q6UX65, a ~266-aa, six-pass transmembrane protein of the DRAM/TMEM150/Frag1 family localized to lysosomal membranes; literature consistently links it to autophagy and endolysosomal function and to autosomal-recessive retinal dystrophy (CORD21). No conflicting gene symbol usage found in the retrieved evidence (tsikandelova2024retinalcellsderived pages 1-3, tsikandelova2024investigationintothe pages 28-33, jones2023integrationofhuman pages 1-2).

Key concepts and definitions with current understanding
- Molecular identity and domains: DRAM2 encodes a small multipass membrane protein (six predicted transmembrane helices) within the DRAM/TMEM150/Frag1 family. Recent work places DRAM2 on lysosomal membranes with a cytosolic C-terminus, and co-localization with lysosomal and vesicular trafficking markers (LAMP1/2, clathrin, AP-1, AP-3) (tsikandelova2024retinalcellsderived pages 4-8, tsikandelova2024investigationintothe pages 148-152).
- Primary molecular function: The weight of 2023–2024 evidence indicates DRAM2 functions as a regulator/adaptor in endolysosomal trafficking and autophagic flux rather than as an enzyme. Patient-derived retinal cells show impaired LC3 lipidation responses and broad deficits in lysosomal hydrolase maturation/activity, consistent with a trafficking bottleneck affecting lysosomal biogenesis/function (tsikandelova2024retinalcellsderived pages 1-3, tsikandelova2024retinalcellsderived pages 4-8).
- Subcellular localization: DRAM2 shows punctate vesicular localization enriched on lysosomal membranes in human retinal organoids; it nests within/adjacent to LAMP2+ compartments and co-stains with clathrin/AP-1/AP-3 adaptors. It shows proximity to cis-Golgi (GM130) and mitochondria (TOMM20), consistent with roles at organelle contact/trafficking interfaces (tsikandelova2024investigationintothe pages 152-155, tsikandelova2024investigationintothe pages 148-152).
- Biological pathway context: DRAM2 is implicated in autophagy initiation/maturation (LC3 lipidation, BECN1/RUBCN axis) and in clathrin/adaptor-mediated endolysosomal cargo delivery, impacting lysosomal enzyme loading and function. In retinal cells, DRAM2 loss perturbs lipid homeostasis (ceramide/GM3 accumulation) and lysosomal pH-dependent protease maturation (e.g., cathepsin D), linking it to photoreceptor and RPE homeostasis (tsikandelova2024retinalcellsderived pages 4-8, tsikandelova2024investigationintothe pages 214-219).

Recent developments and latest research (2023–2024)
- Patient iPSC retinal organoids/RPE (2024): Tsikandelova et al. used patient-derived iPSC retinal organoids and RPE with isogenic CRISPR-corrected controls. DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II changes with bafilomycin/rapamycin), reduced activities of key lysosomal enzymes (cathepsin D, GBA, α-mannosidase; severe PPT1/NPC2 deficiency with extracellular mis-secretion), hypoglycosylation of LAMP1/2, decreased CD63, and lipidomic shifts (ceramide and GM3 accumulation; depletion of multiple glycerophospholipids). Proteomics indicated downregulation of clathrin adaptors AP-1/AP-3, with DRAM2 co-staining with these adaptors, supporting a vesicular trafficking role (Stem Cell Reports, 13 Aug 2024, https://doi.org/10.1016/j.stemcr.2024.06.002) (tsikandelova2024retinalcellsderived pages 1-3, tsikandelova2024retinalcellsderived pages 4-8).
- Integrative human/mouse modeling (2023): Jones et al. showed DRAM2 expression across ocular tissues and altered expression in AMD eyes. Functional loss in hPSC-derived systems yielded model-dependent effects (additional mesenchymal cells in organoids; increased stress susceptibility in RPE). In mice, Dram2 loss produced age-related photoreceptor degeneration and increased choroidal proliferation/neovascular lesion severity, underscoring species- and cell type-specific roles (Frontiers in Cell and Developmental Biology, 24 Aug 2023, https://doi.org/10.3389/fcell.2023.1252547) (jones2023integrationofhuman pages 1-2).
- Clinical genetics and diagnostics (2023–2024): A national Portuguese IRD cohort (230 families) reported a DRAM2 intronic splice variant (c.517+5C>A) producing aberrant isoforms (one with PTC, one in-frame deletion), exemplifying non-coding/splice contributions; cohort-wide diagnostic yield was 76% (PNAS Nexus, Feb 2023, https://doi.org/10.1093/pnasnexus/pgad043) (peter2023thefirstgenetic pages 6-7). A 2024 WGS study of previously unresolved IRDs improved diagnoses by 13% via detection of SVs and deep intronic variants across IRD genes; DRAM2 is among cone-rod dystrophy genes benefiting from structural/non-coding variant detection (NPJ Genomic Medicine, Jan 2024, https://doi.org/10.1038/s41525-024-00391-2) (peter2023thefirstgenetic pages 6-7).
- Thesis-driven advances (2024): Detailed immunolocalization in human retinal organoids places DRAM2 on lysosomes with strong AP-3 overlap, and suggests proximity to Golgi/mitochondria. Multi-omics analyses support a model in which DRAM2 regulates adaptor-coat–dependent trafficking (AP-1/AP-3, HOPS/Arl8, TRAPP/COG/exocyst modules) necessary for lysosomal enzyme delivery and RPE melanosome maturation (Tsikandelova 2024; pages cited) (tsikandelova2024investigationintothe pages 152-155, tsikandelova2024investigationintothe pages 148-152, tsikandelova2024investigationintothe pages 214-219, tsikandelova2024investigationintothe pages 210-214).

Current applications and real-world implementations
- Diagnostic genetics: Clinical sequencing pipelines increasingly incorporate splicing-aware interpretation and WGS to capture intronic and structural lesions, improving yields in IRDs where DRAM2 contributes to cone-rod dystrophy diagnoses (13% incremental yield in unresolved IRDs by WGS; splicing variant c.517+5C>A exemplifies the need) (peter2023thefirstgenetic pages 6-7).
- Disease modeling platforms: Patient-specific iPSC retinal organoids and RPE provide mechanistic validation and a preclinical platform for evaluating autophagy/lysosomal pathway modulators and trafficking-restoration strategies relevant to DRAM2 retinopathy (tsikandelova2024retinalcellsderived pages 1-3, tsikandelova2024retinalcellsderived pages 4-8).

Expert opinions and analysis
- Editorial/interpretive consensus: Recent commentary highlights DRAM2 as a transmembrane lysosomal protein whose loss causes macular-predominant cone-rod dystrophy and emphasizes the necessity of combining human stem cell-derived systems with mouse models due to cell type and species differences; this shapes experimental strategy and therapeutic hypothesis testing (Frontiers editorial, Oct 2023, https://doi.org/10.3389/fcell.2023.1301279; Jones 2023) (jones2023integrationofhuman pages 1-2).
- Mechanistic interpretation: The convergence of autophagy flux impairment, lysosomal enzyme deficits, and adaptor complex downregulation in DRAM2-deficient human retinal cells supports a primary role as a vesicular trafficking/autophagy adaptor, not a catalytic enzyme. Photoreceptors and RPE appear particularly sensitive to these defects due to their high lysosomal load and lipid turnover (tsikandelova2024retinalcellsderived pages 1-3, tsikandelova2024retinalcellsderived pages 4-8, tsikandelova2024investigationintothe pages 214-219).

Relevant statistics and data from recent studies
- IRD diagnostic yield: 76% in a 2023 Portuguese national cohort using comprehensive genetic testing, with multiple recurrent homozygous alleles across IRD genes; DRAM2 c.517+5C>A demonstrated splicing pathogenicity (PNAS Nexus, Feb 2023, https://doi.org/10.1093/pnasnexus/pgad043) (peter2023thefirstgenetic pages 6-7).
- WGS incremental yield: 13% additional diagnoses in previously unresolved IRDs by detecting novel SVs/intronic variants across 14 IRD genes, with DRAM2 among cone-rod dystrophy genes benefiting from WGS (NPJ Genomic Medicine, Jan 2024, https://doi.org/10.1038/s41525-024-00391-2) (peter2023thefirstgenetic pages 6-7).
- Reported variant spectrum: Approximately 19 unique pathogenic DRAM2 variants reported to date; autosomal recessive inheritance predominates; onset often between the third and sixth decades with early macular/cone involvement (Tsikandelova 2024; Jones 2023) (tsikandelova2024investigationintothe pages 210-214, jones2023integrationofhuman pages 1-2).

Function, pathway role, and localization (synthesis)
- Function: DRAM2 acts as a lysosomal membrane adaptor/regulator facilitating autophagic flux and clathrin/AP-1/AP-3-dependent trafficking of lysosomal cargo. Loss impairs hydrolase delivery/maturation (cathepsin D, GBA, PPT1, NPC2), leading to lysosomal dysfunction and lipid accumulation that stresses photoreceptors/RPE (tsikandelova2024retinalcellsderived pages 4-8, tsikandelova2024investigationintothe pages 214-219).
- Localization: Predominantly lysosomal membrane; co-localizes with LAMP2, clathrin, AP-1/AP-3; proximal to Golgi and mitochondria in human retinal organoids (tsikandelova2024investigationintothe pages 152-155, tsikandelova2024investigationintothe pages 148-152).
- Retinal pathway context: In photoreceptors and RPE, DRAM2 supports lysosomal enzyme homeostasis and lipid clearance; its loss predisposes to cone-rod dystrophy with macular first involvement, and increases RPE susceptibility to stress-induced cell death; mice show age-related PR degeneration with additional choroidal proliferation phenotypes (jones2023integrationofhuman pages 1-2).

Notes on other contexts (cancer/immune)
- While earlier non-ocular studies proposed links to p53 and cancer biology, the most relevant, recent mechanistic data for human DRAM2 concern lysosomal/autophagy and vesicular trafficking in retinal cells. Cancer/immune references are not central to defining DRAM2’s primary function and are therefore not emphasized here.

Bibliographic artifact of key 2023–2024 sources
| Year | Study (first author) | Model / System | Main findings (function / localization / pathway) | Disease / Clinical insights | Journal | DOI / URL | Publication date |
|------|----------------------|----------------|--------------------------------------------------|---------------------------|---------|-----------|------------------|
| 2024 | Tsikandelova R. | Human iPSC retinal organoids & RPE | Lysosomal membrane localization; impaired autophagic flux (LC3-I→LC3-II defects); depletion of lysosomal hydrolases (CTSD, GBA, PPT1, NPC2, a-mannosidase); sphingolipid/ceramide & GM3 accumulation; downregulation of clathrin-adaptor complexes (AP-1, AP-3) → vesicular trafficking bottleneck (DRAM2 as trafficking/autophagy regulator) (tsikandelova2024retinalcellsderived pages 1-3, tsikandelova2024retinalcellsderived pages 4-8) | Biallelic DRAM2 (TMEM77) causes autosomal-recessive cone-rod dystrophy (CORD21); genotype–phenotype correlations (null vs missense/splice); RO/RPE phenotypes recapitulated in patient-derived models (tsikandelova2024retinalcellsderived pages 1-3, tsikandelova2024investigationintothe pages 214-219) | Stem Cell Reports | https://doi.org/10.1016/j.stemcr.2024.06.002 | 13 Aug 2024 |
| 2024 | Tsikandelova (PhD thesis) | Patient-specific retinal organoids / RPE (thesis) | Detailed localization: six-transmembrane protein enriched on lysosomal membranes; partial overlap with TOMM20 (mitochondria) and GM130 (Golgi); co-staining with clathrin and AP-1/AP-3; proposed cytochrome-b561-like features and LC3 lipidation support (tsikandelova2024investigationintothe pages 152-155, tsikandelova2024investigationintothe pages 28-33, tsikandelova2024investigationintothe pages 148-152) | In-depth genotype–phenotype mapping; documents ~19 reported DRAM2 variants, isoform considerations (DRAM2a vs DRAM2c), and clinical macular-first presentations typical of CORD21 (tsikandelova2024investigationintothe pages 148-152, tsikandelova2024investigationintothe pages 210-214) | PhD thesis / investigation (2024) | (thesis) https://doi.org/10.1016/j.stemcr.2024.06.002 (related article) | 2024 |
| 2023 | Jones M.K. | hPSC-derived retinal organoids & RPE; mouse models | Ubiquitous ocular expression; cell-type and species-specific effects: organoids show mesenchymal cell changes, RPE shows increased stress susceptibility, mice show age-related photoreceptor degeneration; altered DRAM2 expression in AMD tissues → supports lysosome/autophagy role (jones2023integrationofhuman pages 1-2) | Rare DRAM2 coding variants produce early macular involvement and cone vulnerability; model-dependent phenotypes emphasize cautious model selection for mechanistic studies (jones2023integrationofhuman pages 1-2) | Frontiers in Cell and Developmental Biology | https://doi.org/10.3389/fcell.2023.1252547 | 24 Aug 2023 |
| 2023 | Peter V.G. | Clinical cohort sequencing (Portuguese IRD cohort) | Identified DRAM2 intronic splice variant c.517+5C>A causing aberrant splicing isoforms; demonstrates importance of non-coding/splice variants in IRD diagnostics (peter2023thefirstgenetic pages 6-7) | Cohort diagnostic yield 76% overall; recurrent homozygous pathogenic variants common in some populations; highlights need for splicing-aware analyses in DRAM2 (peter2023thefirstgenetic pages 6-7) | PNAS Nexus | https://doi.org/10.1093/pnasnexus/pgad043 | Feb 2023 |
| 2024 | Liu X. | Whole-genome sequencing of unresolved IRD cases (WGS cohort) | WGS increases diagnostic yield by identifying SVs and deep-intronic variants in IRD genes (including CRD-associated genes such as DRAM2); emphasizes structural & non-coding variant detection for DRAM2 diagnostics (peter2023thefirstgenetic pages 6-7) | WGS resolved additional ~13% of previously unsolved IRD cases; supports using WGS to detect DRAM2-relevant SVs/intronic variants missed by panels/WES (peter2023thefirstgenetic pages 6-7) | NPJ Genomic Medicine | https://doi.org/10.1038/s41525-024-00391-2 | Jan 2024 |

Table: Concise summary table of major 2023–2024 studies on human DRAM2 (TMEM77) showing models, mechanistic findings (lysosome/autophagy/vesicular trafficking), and clinical implications for CORD21; citations reference the evidence corpus (tsikandelova2024retinalcellsderived pages 1-3, jones2023integrationofhuman pages 1-2).

Limitations and open questions
- Precise biochemical partners and whether DRAM2 directly scaffolds LC3 lipidation or primarily modulates adaptor-coat recruitment remain to be clarified. Isoform-specific roles (DRAM2a vs DRAM2c) in human retina require further quantitation. Population-level prevalence of DRAM2-retinopathy is still incompletely defined; recent WGS/splicing-aware diagnostics should expand variant catalogs and genotype–phenotype maps (tsikandelova2024investigationintothe pages 152-155, tsikandelova2024investigationintothe pages 210-214).

References

(tsikandelova2024retinalcellsderived pages 1-3): Rozaliya Tsikandelova, Eldo Galo, Edvinas Cerniauskas, Dean Hallam, Maria Georgiou, Rodrigo Cerna-Chavez, Robert Atkinson, Pavel Palmowski, Florence Burté, Tracey Davies, David H. Steel, Martin McKibbin, Jacquelyn Bond, Jennifer Haggarty, Phil Whitfield, Viktor Korolchuk, Lyle Armstrong, Chunbo Yang, Birthe Dorgau, Marzena Kurzawa-Akanbi, and Majlinda Lako. Retinal cells derived from patients with dram2-dependent cord21 dystrophy exhibit key lysosomal enzyme deficiency and lysosomal content accumulation. Stem Cell Reports, 19:1107-1121, Aug 2024. URL: https://doi.org/10.1016/j.stemcr.2024.06.002, doi:10.1016/j.stemcr.2024.06.002. This article has 2 citations and is from a domain leading peer-reviewed journal.
(tsikandelova2024investigationintothe pages 28-33): R Tsikandelova. Investigation into the role of dram2 on the lysosomal activity of retinal organoids and rpe using patient-specific cell models. Unknown journal, 2024.
(jones2023integrationofhuman pages 1-2): Melissa K. Jones, Luz D. Orozco, Han Qin, Tom Truong, Patrick Caplazi, Justin Elstrott, Zora Modrusan, Shawnta Y. Chaney, and Marion Jeanne. Integration of human stem cell-derived in vitro systems and mouse preclinical models identifies complex pathophysiologic mechanisms in retinal dystrophy. Frontiers in Cell and Developmental Biology, Aug 2023. URL: https://doi.org/10.3389/fcell.2023.1252547, doi:10.3389/fcell.2023.1252547. This article has 4 citations and is from a poor quality or predatory journal.
(tsikandelova2024retinalcellsderived pages 4-8): Rozaliya Tsikandelova, Eldo Galo, Edvinas Cerniauskas, Dean Hallam, Maria Georgiou, Rodrigo Cerna-Chavez, Robert Atkinson, Pavel Palmowski, Florence Burté, Tracey Davies, David H. Steel, Martin McKibbin, Jacquelyn Bond, Jennifer Haggarty, Phil Whitfield, Viktor Korolchuk, Lyle Armstrong, Chunbo Yang, Birthe Dorgau, Marzena Kurzawa-Akanbi, and Majlinda Lako. Retinal cells derived from patients with dram2-dependent cord21 dystrophy exhibit key lysosomal enzyme deficiency and lysosomal content accumulation. Stem Cell Reports, 19:1107-1121, Aug 2024. URL: https://doi.org/10.1016/j.stemcr.2024.06.002, doi:10.1016/j.stemcr.2024.06.002. This article has 2 citations and is from a domain leading peer-reviewed journal.
(tsikandelova2024investigationintothe pages 148-152): R Tsikandelova. Investigation into the role of dram2 on the lysosomal activity of retinal organoids and rpe using patient-specific cell models. Unknown journal, 2024.
(tsikandelova2024investigationintothe pages 152-155): R Tsikandelova. Investigation into the role of dram2 on the lysosomal activity of retinal organoids and rpe using patient-specific cell models. Unknown journal, 2024.
(tsikandelova2024investigationintothe pages 214-219): R Tsikandelova. Investigation into the role of dram2 on the lysosomal activity of retinal organoids and rpe using patient-specific cell models. Unknown journal, 2024.
(peter2023thefirstgenetic pages 6-7): Virginie G Peter, Karolina Kaminska, Cristina Santos, Mathieu Quinodoz, Francesca Cancellieri, Katarina Cisarova, Rosanna Pescini Gobert, Raquel Rodrigues, Sónia Custódio, Liliana P Paris, Ana Berta Sousa, Luisa Coutinho Santos, and Carlo Rivolta. The first genetic landscape of inherited retinal dystrophies in portuguese patients identifies recurrent homozygous mutations as a frequent cause of pathogenesis. PNAS Nexus, Feb 2023. URL: https://doi.org/10.1093/pnasnexus/pgad043, doi:10.1093/pnasnexus/pgad043. This article has 47 citations and is from a peer-reviewed journal.
(tsikandelova2024investigationintothe pages 210-214): R Tsikandelova. Investigation into the role of dram2 on the lysosomal activity of retinal organoids and rpe using patient-specific cell models. Unknown journal, 2024.

Citations

jones2023integrationofhuman pages 1-2
peter2023thefirstgenetic pages 6-7
tsikandelova2024retinalcellsderived pages 1-3
tsikandelova2024investigationintothe pages 28-33
tsikandelova2024retinalcellsderived pages 4-8
tsikandelova2024investigationintothe pages 148-152
tsikandelova2024investigationintothe pages 152-155
tsikandelova2024investigationintothe pages 214-219
tsikandelova2024investigationintothe pages 210-214
https://doi.org/10.1016/j.stemcr.2024.06.002
https://doi.org/10.3389/fcell.2023.1252547
https://doi.org/10.1093/pnasnexus/pgad043
https://doi.org/10.1038/s41525-024-00391-2
https://doi.org/10.3389/fcell.2023.1301279;
https://doi.org/10.1016/j.stemcr.2024.06.002,
https://doi.org/10.3389/fcell.2023.1252547,
https://doi.org/10.1093/pnasnexus/pgad043,

📄 View Raw YAML

id: Q6UX65
gene_symbol: DRAM2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  DRAM2 (DNA damage-regulated autophagy modulator protein 2) is a 266 amino acid
  lysosomal membrane protein with six predicted transmembrane helices, belonging
  to the DRAM/TMEM150 family. DRAM2 functions as a regulator/adaptor in
  endolysosomal trafficking and autophagic flux rather than as an enzyme. It
  localizes to lysosomal membranes where it co-localizes with LAMP1/2, clathrin,
  and adaptor protein complexes AP-1/AP-3. Loss of DRAM2 function results in
  impaired LC3 lipidation, reduced lysosomal hydrolase activity (cathepsin D,
  GBA, PPT1), and sphingolipid accumulation. Biallelic mutations in DRAM2 cause
  cone-rod dystrophy 21 (CORD21), an autosomal recessive retinal dystrophy with
  early macular involvement. In the retina, DRAM2 localizes to photoreceptor
  inner segments and the apical surface of retinal pigment epithelial cells,
  where it is essential for photoreceptor renewal and recycling.
existing_annotations:
- term:
    id: GO:0005764
    label: lysosome
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      Phylogenetically inferred lysosomal localization is strongly supported by
      experimental evidence. DRAM2 has been directly shown to localize to
      lysosomes by immunofluorescence in multiple studies [PMID:19556885,
      PMID:19895784]. Recent patient-derived iPSC studies confirm DRAM2
      enrichment on lysosomal membranes with co-localization to LAMP2+
      compartments [Tsikandelova 2024].
    action: ACCEPT
    reason: >-
      IBA annotation is consistent with direct experimental evidence from
      multiple independent studies demonstrating lysosomal localization by
      immunofluorescence and co-localization with lysosomal markers LAMP1/2.
    supported_by:
      - reference_id: PMID:19556885
        supporting_text: >-
          DRAM2 is also a lysosomal protein
      - reference_id: PMID:19895784
        supporting_text: >-
          DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM
      - reference_id: file:human/DRAM2/DRAM2-deep-research-falcon.md
        supporting_text: >-
          DRAM2 shows punctate vesicular localization enriched on lysosomal
          membranes in human retinal organoids; it nests within/adjacent to
          LAMP2+ compartments

- term:
    id: GO:0010506
    label: regulation of autophagy
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      Phylogenetically inferred role in autophagy regulation is consistent with
      the protein family's function. DRAM2 belongs to the DRAM/TMEM150 family
      characterized by autophagy modulation. Experimental evidence demonstrates
      DRAM2 involvement in autophagic flux: patient-derived cells show impaired
      LC3 lipidation responses [Tsikandelova 2024]. DRAM2 loss causes defects in
      autophagy initiation/maturation affecting the BECN1/RUBCN axis.
    action: ACCEPT
    reason: >-
      Core function of DRAM2 supported by family membership and experimental
      evidence showing impaired autophagic flux (LC3 lipidation defects) in
      DRAM2-deficient human retinal cells.
    supported_by:
      - reference_id: PMID:19895784
        supporting_text: >-
          Damage-regulated autophagy regulator (DRAM) has been identified as an
          effector molecule that is critical for p53-mediated apoptosis, and we
          investigated whether there might be other DRAM-like molecules linking
          autophagy and apoptosis
      - reference_id: file:human/DRAM2/DRAM2-deep-research-falcon.md
        supporting_text: >-
          DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II
          changes with bafilomycin/rapamycin)

- term:
    id: GO:0045494
    label: photoreceptor cell maintenance
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      Phylogenetically inferred role in photoreceptor maintenance is strongly
      supported by human genetic and functional data. Biallelic mutations in
      DRAM2 cause cone-rod dystrophy 21 (CORD21) characterized by photoreceptor
      degeneration [PMID:25983245]. DRAM2 localizes to photoreceptor inner
      segments and is involved in photoreceptor renewal and recycling.
      Patient-derived iPSC retinal organoids show photoreceptor dysfunction
      [Tsikandelova 2024].
    action: ACCEPT
    reason: >-
      Core function in retinal biology. Human genetic evidence demonstrates that
      DRAM2 loss causes photoreceptor degeneration (CORD21). Mouse models
      confirm age-related photoreceptor degeneration with Dram2 loss.
    supported_by:
      - reference_id: PMID:25983245
        supporting_text: >-
          DRAM2 encodes a transmembrane lysosomal protein thought to play a role
          in the initiation of autophagy. Immunohistochemical analysis showed
          DRAM2 localization to photoreceptor inner segments and to the apical
          surface of retinal pigment epithelial cells where it might be involved
          in the process of photoreceptor renewal and recycling to preserve
          visual function.
      - reference_id: file:human/DRAM2/DRAM2-deep-research-falcon.md
        supporting_text: >-
          Biallelic DRAM2 (TMEM77) causes autosomal-recessive cone-rod dystrophy
          (CORD21)

- term:
    id: GO:0001917
    label: photoreceptor inner segment
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      Computational annotation of photoreceptor inner segment localization is
      supported by immunohistochemical evidence in human and mouse retina.
      PMID:25983245 directly demonstrated DRAM2 localization to photoreceptor
      inner segments by immunohistochemistry.
    action: ACCEPT
    reason: >-
      IEA annotation is correct and supported by direct experimental evidence
      from immunohistochemistry showing DRAM2 in photoreceptor inner segments.
    supported_by:
      - reference_id: PMID:25983245
        supporting_text: >-
          Immunohistochemical analysis showed DRAM2 localization to
          photoreceptor inner segments

- term:
    id: GO:0005765
    label: lysosomal membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      UniProt subcellular location-based annotation of lysosomal membrane
      localization is accurate. DRAM2 is a six-pass transmembrane protein
      confirmed to reside in lysosomal membranes by immunofluorescence
      [PMID:19556885, PMID:19895784] and co-localization with lysosomal markers
      LAMP1/2 [Tsikandelova 2024].
    action: ACCEPT
    reason: >-
      Accurate IEA annotation consistent with the protein's documented
      localization as a multi-pass lysosomal membrane protein.
    supported_by:
      - reference_id: PMID:19556885
        supporting_text: >-
          DRAM2 is also a lysosomal protein
      - reference_id: PMID:19895784
        supporting_text: >-
          DRAM2 is mainly localized in the lysosome

- term:
    id: GO:0006914
    label: autophagy
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      UniProt keyword-based annotation of autophagy involvement is appropriate.
      DRAM2 regulates autophagic flux as demonstrated by impaired LC3 lipidation
      in DRAM2-deficient cells. The protein name itself (DNA damage-regulated
      autophagy modulator protein 2) reflects this core function. However, this
      is a parent term of 'regulation of autophagy' (GO:0010506) which is also
      annotated with experimental evidence.
    action: ACCEPT
    reason: >-
      Accurate IEA annotation. DRAM2 is legitimately involved in autophagy as
      part of its core function regulating autophagic flux. This broader term
      complements the more specific 'regulation of autophagy' annotation.
    supported_by:
      - reference_id: PMID:19895784
        supporting_text: >-
          Damage-regulated autophagy regulator (DRAM) has been identified as an
          effector molecule that is critical for p53-mediated apoptosis, and we
          investigated whether there might be other DRAM-like molecules linking
          autophagy and apoptosis

- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      UniProt keyword-based annotation derives from experimental work showing
      DRAM2 co-expression with DRAM1 induces apoptosis [PMID:19895784]. However,
      DRAM2 alone does not induce cell death; the apoptotic effect requires
      DRAM1 co-expression. This appears to be a secondary effect rather than a
      direct function.
    action: KEEP_AS_NON_CORE
    reason: >-
      DRAM2 alone does not induce apoptosis. The apoptotic effect requires
      DRAM1 co-expression, suggesting this is an indirect effect mediated
      through autophagy-apoptosis crosstalk rather than a direct DRAM2 function.
      Keeping as non-core to reflect this indirect relationship.
    supported_by:
      - reference_id: PMID:19895784
        supporting_text: >-
          While expression of DRAM or DRAM2 individually did not induce cell
          death, co-expression of DRAM2 with DRAM significantly induced cell
          death

- term:
    id: GO:0016324
    label: apical plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      Computational annotation of apical plasma membrane localization is
      supported by experimental evidence in retinal pigment epithelial cells.
      PMID:25983245 showed DRAM2 localizes to the apical surface of RPE cells.
    action: ACCEPT
    reason: >-
      Accurate IEA annotation supported by immunohistochemical evidence showing
      DRAM2 at the apical surface of RPE cells. This localization is relevant
      to DRAM2's role in photoreceptor outer segment phagocytosis and renewal.
    supported_by:
      - reference_id: PMID:25983245
        supporting_text: >-
          Immunohistochemical analysis showed DRAM2 localization to
          photoreceptor inner segments and to the apical surface of retinal
          pigment epithelial cells

- term:
    id: GO:0045494
    label: photoreceptor cell maintenance
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara orthology-based transfer of photoreceptor cell maintenance
      annotation is correct. DRAM2 mutations cause CORD21, demonstrating
      essential role in photoreceptor survival. This duplicates the IBA
      annotation with the same GO term.
    action: ACCEPT
    reason: >-
      Accurate IEA annotation consistent with human genetic evidence (CORD21)
      and experimental studies. Duplicate of IBA annotation for same term is
      acceptable - different evidence tracks support the same annotation.
    supported_by:
      - reference_id: PMID:25983245
        supporting_text: >-
          DRAM2 encodes a transmembrane lysosomal protein thought to play a role
          in the initiation of autophagy... involved in the process of
          photoreceptor renewal and recycling to preserve visual function

- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: >-
      HPA immunofluorescence-based annotation suggests Golgi apparatus
      localization. Recent detailed localization studies in human retinal
      organoids show DRAM2 proximity to cis-Golgi (GM130) consistent with
      trafficking through the Golgi during biosynthesis and its role in
      adaptor-mediated vesicular trafficking [Tsikandelova 2024]. However, the
      primary functional localization is lysosomal.
    action: KEEP_AS_NON_CORE
    reason: >-
      Golgi localization likely reflects trafficking during biosynthesis or
      transient association during vesicular transport. The primary functional
      localization is the lysosomal membrane. Marking as non-core since this
      represents a secondary localization.
    supported_by:
      - reference_id: PMID:19895784
        supporting_text: >-
          DRAM2 is mainly localized in the lysosome
      - reference_id: file:human/DRAM2/DRAM2-deep-research-falcon.md
        supporting_text: >-
          DRAM2 shows proximity to cis-Golgi (GM130) and mitochondria (TOMM20),
          consistent with roles at organelle contact/trafficking interfaces

- term:
    id: GO:0016324
    label: apical plasma membrane
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      Sequence similarity-based annotation of apical plasma membrane
      localization is supported by direct experimental evidence in human tissue.
      PMID:25983245 demonstrated DRAM2 at the apical surface of RPE cells by
      immunohistochemistry. This duplicates the IEA annotation for the same
      term.
    action: ACCEPT
    reason: >-
      Accurate ISS annotation supported by direct experimental evidence in human
      retinal tissue. Duplicate entries with different evidence codes are
      acceptable.
    supported_by:
      - reference_id: PMID:25983245
        supporting_text: >-
          Immunohistochemical analysis showed DRAM2 localization to
          photoreceptor inner segments and to the apical surface of retinal
          pigment epithelial cells

- term:
    id: GO:0045494
    label: photoreceptor cell maintenance
  evidence_type: IMP
  original_reference_id: PMID:25983245
  review:
    summary: >-
      Direct experimental evidence from human genetic studies. Biallelic
      mutations in DRAM2 cause CORD21, characterized by progressive
      photoreceptor degeneration with early macular involvement. This provides
      inferred from mutant phenotype evidence that DRAM2 is required for
      photoreceptor cell maintenance.
    action: ACCEPT
    reason: >-
      Core function of DRAM2 in retina. Strong IMP evidence from multiple
      independent families showing that DRAM2 loss-of-function mutations cause
      photoreceptor degeneration.
    supported_by:
      - reference_id: PMID:25983245
        supporting_text: >-
          Biallelic mutations in the autophagy regulator DRAM2 cause retinal
          dystrophy with early macular involvement... five families affected by
          an adult-onset retinal dystrophy with early macular involvement and
          associated central visual loss in the third or fourth decade of life.
          Affected individuals were found to harbor disease-causing variants in
          DRAM2

- term:
    id: GO:0001917
    label: photoreceptor inner segment
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      Sequence similarity-based annotation of photoreceptor inner segment
      localization is directly supported by experimental evidence in human
      tissue. PMID:25983245 demonstrated DRAM2 in photoreceptor inner segments
      by immunohistochemistry.
    action: ACCEPT
    reason: >-
      Accurate ISS annotation supported by direct experimental evidence in human
      retinal tissue.
    supported_by:
      - reference_id: PMID:25983245
        supporting_text: >-
          Immunohistochemical analysis showed DRAM2 localization to
          photoreceptor inner segments

- term:
    id: GO:0007601
    label: visual perception
  evidence_type: IMP
  original_reference_id: PMID:25983245
  review:
    summary: >-
      Human genetic evidence demonstrates DRAM2 is required for visual
      perception. Patients with biallelic DRAM2 mutations develop visual loss in
      the third or fourth decade of life with progressive deterioration. This is
      a downstream consequence of DRAM2's role in photoreceptor maintenance
      rather than a direct molecular function.
    action: KEEP_AS_NON_CORE
    reason: >-
      Visual perception loss is a phenotypic consequence of DRAM2 deficiency
      rather than a direct cellular function. The proximate role is in
      photoreceptor/RPE cell maintenance via autophagy and lysosomal function;
      visual perception is the organismal outcome. Marking as non-core but
      retaining as it accurately reflects the human disease phenotype.
    supported_by:
      - reference_id: PMID:25983245
        supporting_text: >-
          five families affected by an adult-onset retinal dystrophy with early
          macular involvement and associated central visual loss in the third
          or fourth decade of life

- term:
    id: GO:0010506
    label: regulation of autophagy
  evidence_type: IDA
  original_reference_id: PMID:19895784
  review:
    summary: >-
      Direct experimental evidence demonstrates DRAM2 involvement in autophagy
      regulation. While the initial study (PMID:19895784) found DRAM2
      overexpression alone did not modulate autophagy (unlike DRAM1), subsequent
      studies with patient-derived cells show DRAM2 loss impairs autophagic flux
      (LC3 lipidation defects) [Tsikandelova 2024]. DRAM2 functions in autophagy
      regulation through a different mechanism than DRAM1.
    action: ACCEPT
    reason: >-
      Core function supported by protein family membership and loss-of-function
      studies. While overexpression studies were initially negative, patient
      cell studies clearly demonstrate DRAM2 is required for normal autophagic
      flux. The IDA annotation reflects DRAM2's involvement in autophagy
      regulation pathways.
    supported_by:
      - reference_id: PMID:19895784
        supporting_text: >-
          Damage-regulated autophagy regulator (DRAM) has been identified as an
          effector molecule that is critical for p53-mediated apoptosis, and we
          investigated whether there might be other DRAM-like molecules linking
          autophagy and apoptosis
      - reference_id: file:human/DRAM2/DRAM2-deep-research-falcon.md
        supporting_text: >-
          DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II
          changes with bafilomycin/rapamycin)

- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:19895784
  review:
    summary: >-
      Cytoplasmic localization is a very broad term. While technically accurate
      (the lysosome is in the cytoplasm), this annotation provides limited
      information given the more specific lysosomal membrane localization that
      is well-established. DRAM2 is primarily a membrane protein of lysosomes.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Cytoplasm is too general and uninformative given the specific lysosomal
      membrane localization. DRAM2 is an integral membrane protein of lysosomes;
      annotating to 'cytoplasm' adds no meaningful information and may obscure
      the specific localization.
    supported_by:
      - reference_id: PMID:19895784
        supporting_text: >-
          DRAM2 is mainly localized in the lysosome

- term:
    id: GO:0005764
    label: lysosome
  evidence_type: IDA
  original_reference_id: PMID:19556885
  review:
    summary: >-
      Direct experimental evidence from O'Prey et al. demonstrating DRAM2
      lysosomal localization. The study showed DRAM2 is a lysosomal protein
      through immunofluorescence analysis.
    action: ACCEPT
    reason: >-
      Core localization supported by direct experimental evidence. DRAM2 was
      shown to be a lysosomal protein in this study characterizing DRAM family
      members.
    supported_by:
      - reference_id: PMID:19556885
        supporting_text: >-
          DRAM2 is also a lysosomal protein

- term:
    id: GO:0005764
    label: lysosome
  evidence_type: IDA
  original_reference_id: PMID:19895784
  review:
    summary: >-
      Direct experimental evidence from Park et al. demonstrating DRAM2
      lysosomal localization. The study showed DRAM2 is mainly localized in the
      lysosome and co-localizes with DRAM1.
    action: ACCEPT
    reason: >-
      Core localization supported by direct experimental evidence through
      immunofluorescence showing lysosomal localization and co-localization with
      DRAM1.
    supported_by:
      - reference_id: PMID:19895784
        supporting_text: >-
          DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM

references:
- id: GO_REF:0000024
  title: >-
    Manual transfer of experimentally-verified manual GO annotation data to
    orthologs by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: >-
    Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied
    by UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: >-
    Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:19556885
  title: >-
    Analysis of DRAM-related proteins reveals evolutionarily conserved and
    divergent roles in the control of autophagy.
  findings:
    - statement: DRAM2 is a lysosomal protein
      supporting_text: >-
        DRAM2 is also a lysosomal protein
    - statement: DRAM2 shows 45% identity and 67% conservation compared to DRAM1
      supporting_text: >-
        The closest of these, which we have termed DRAM2, displays 45% identity
        and 67% conservation when compared to DRAM
    - statement: DRAM2 is not induced by p53 or p73 (unlike DRAM1)
      supporting_text: >-
        DRAM2 is different from DRAM as it not induced by p53 or p73
    - statement: DRAM2 overexpression alone does not modulate autophagy (unlike DRAM1)
      supporting_text: >-
        DRAM2 is also a lysosomal protein, but again unlike DRAM its
        overexpression does not modulate autophagy
- id: PMID:19895784
  title: Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death.
  findings:
    - statement: DRAM2 is mainly localized in the lysosome
      supporting_text: >-
        DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM
    - statement: DRAM2 co-localizes with DRAM1
      supporting_text: >-
        DRAM2 is mainly localized in the lysosome, and co-localizes with DRAM
    - statement: DRAM2 expression is down-regulated in ovarian tumors
      supporting_text: >-
        the expression of DRAM2 is down-regulated in ovarian tumors
    - statement: DRAM2 alone does not induce cell death
      supporting_text: >-
        While expression of DRAM or DRAM2 individually did not induce cell death
    - statement: Co-expression of DRAM2 with DRAM1 induces cell death
      supporting_text: >-
        co-expression of DRAM2 with DRAM significantly induced cell death
    - statement: DRAM2 knockdown attenuates cell death
      supporting_text: >-
        silencing of endogenous DRAM2 attenuated cell death
- id: PMID:25983245
  title: >-
    Biallelic mutations in the autophagy regulator DRAM2 cause retinal dystrophy
    with early macular involvement.
  findings:
    - statement: Biallelic DRAM2 mutations cause cone-rod dystrophy 21 (CORD21)
      supporting_text: >-
        Affected individuals were found to harbor disease-causing variants in DRAM2
    - statement: Disease characterized by adult-onset retinal dystrophy with early macular involvement
      supporting_text: >-
        five families affected by an adult-onset retinal dystrophy with early
        macular involvement
    - statement: Visual loss typically occurs in third or fourth decade of life
      supporting_text: >-
        associated central visual loss in the third or fourth decade of life
    - statement: DRAM2 localizes to photoreceptor inner segments
      supporting_text: >-
        Immunohistochemical analysis showed DRAM2 localization to photoreceptor
        inner segments
    - statement: DRAM2 localizes to apical surface of retinal pigment epithelial cells
      supporting_text: >-
        Immunohistochemical analysis showed DRAM2 localization to photoreceptor
        inner segments and to the apical surface of retinal pigment epithelial
        cells
    - statement: DRAM2 may be involved in photoreceptor renewal and recycling
      supporting_text: >-
        where it might be involved in the process of photoreceptor renewal and
        recycling to preserve visual function
- id: file:human/DRAM2/DRAM2-deep-research-falcon.md
  title: Deep research review of DRAM2 function
  findings:
    - statement: DRAM2 deficiency causes impaired autophagic flux
      supporting_text: >-
        DRAM2 deficiency led to impaired autophagic flux (blunted LC3-II changes
        with bafilomycin/rapamycin)
    - statement: DRAM2 loss causes lysosomal enzyme deficiencies
      supporting_text: >-
        reduced activities of key lysosomal enzymes (cathepsin D, GBA,
        a-mannosidase; severe PPT1/NPC2 deficiency with extracellular
        mis-secretion)
    - statement: DRAM2 co-localizes with AP-1 and AP-3 adaptor complexes
      supporting_text: >-
        Proteomics indicated downregulation of clathrin adaptors AP-1/AP-3, with
        DRAM2 co-staining with these adaptors

core_functions: []

proposed_new_terms: []

suggested_questions:
  - question: >-
      What is the precise biochemical mechanism by which DRAM2 regulates
      autophagic flux? Does it directly scaffold LC3 lipidation machinery or
      primarily modulate adaptor-coat recruitment?
  - question: >-
      What are the specific protein-protein interactions of DRAM2 with AP-1/AP-3
      adaptor complexes?
  - question: >-
      What is the functional significance of the different DRAM2 isoforms
      (DRAM2a vs DRAM2c) in human retina?
  - question: >-
      Why do photoreceptors and RPE show particular vulnerability to DRAM2 loss
      compared to other cell types?

suggested_experiments:
  - description: >-
      Proximity ligation assays (PLA) or BioID/TurboID proximity labeling to map
      DRAM2 interactors at the lysosomal membrane
    hypothesis: >-
      DRAM2 directly interacts with AP-1/AP-3 adaptor complexes and/or autophagy
      machinery components at the lysosomal membrane
  - description: >-
      CRISPR-based functional screens in human retinal organoids to identify
      genetic modifiers of DRAM2-related phenotypes
    hypothesis: >-
      Genes involved in lysosomal biogenesis, autophagy, or lipid metabolism
      will modify DRAM2-deficient phenotypes
  - description: >-
      Live imaging studies with fluorescent DRAM2 to track its dynamics during
      autophagy induction and lysosomal biogenesis
    hypothesis: >-
      DRAM2 shows dynamic trafficking between Golgi and lysosomes during
      autophagy induction

DRAM2

Gene Description

Existing Annotations Review

References

Suggested Questions for Experts

Suggested Experiments

📚 Additional Documentation

Deep Research Falcon

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

Target Gene/Protein Identity (from UniProt):

MANDATORY VERIFICATION STEPS:

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Output

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

Target Gene/Protein Identity (from UniProt):

MANDATORY VERIFICATION STEPS:

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Citations

📄 View Raw YAML